<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<ReleaseSet Dated="2016-07-04" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" Type="full" xsi:noNamespaceSchemaLocation="http://ftp.ncbi.nlm.nih.gov/pub/clinvar/xsd_public/clinvar_public_1.35.xsd">

<ClinVarSet ID="13173603">
  <RecordStatus>current</RecordStatus>
  <Title>NM_207352.3(CYP4V2):c.802-8_810del17insGC AND Bietti crystalline corneoretinal dystrophy</Title>
  <ReferenceClinVarAssertion DateCreated="2013-01-08" DateLastUpdated="2016-08-29" ID="93199">
    <ClinVarAccession Acc="RCV000032548" Version="5" Type="RCV" DateUpdated="2016-08-29"/>
    <RecordStatus>current</RecordStatus>
    <ClinicalSignificance DateLastEvaluated="2013-06-14">
      <ReviewStatus>no assertion criteria provided</ReviewStatus>
      <Description>Pathogenic</Description>
    </ClinicalSignificance>
    <Assertion Type="variation to disease"/>
    <ObservedIn>
      <Sample>
        <Origin>not provided</Origin>
        <Species TaxonomyId="9606">human</Species>
        <AffectedStatus>not provided</AffectedStatus>
        <NumberTested>1</NumberTested>
      </Sample>
      <Method>
        <Purpose>assert pathogenicity</Purpose>
        <MethodType>literature only</MethodType>
      </Method>
      <Method>
        <MethodType>literature only</MethodType>
      </Method>
      <ObservedData ID="12726580">
        <Attribute Type="Description">not provided</Attribute>
      </ObservedData>
      <ObservedData ID="12726580">
        <Attribute Type="Description">not provided</Attribute>
      </ObservedData>
    </ObservedIn>
    <ObservedIn>
      <Sample>
        <Origin>germline</Origin>
        <Species TaxonomyId="9606">human</Species>
        <AffectedStatus>not provided</AffectedStatus>
      </Sample>
      <Method>
        <MethodType>literature only</MethodType>
      </Method>
      <ObservedData ID="12728007">
        <Attribute Type="Description">In 7 Japanese patients with Bietti crystalline corneoretinal dystrophy (BCD; 210370), Lin et al. (2005) identified homozygosity for an insertion/deletion mutation (c.802-8_810del17insGC) at intron 6 of the CYP4V2 gene that resulted in the skipping of exon 7. All 7 patients also shared homozygosity for 6 closely linked intragenic polymorphic markers, consistent with a founder effect; however, the authors noted that the founder was probably a very distant ancestor because the region of the conserved linked markers was small (6.7-17.1 kb). In a Chinese BCD patient, Lin et al. (2005) identified compound heterozygosity for this mutation and a c.992A-C transversion in the CYP4V2 gene, resulting in a his-331-to-pro (H331P; 608614.0007) substitution.</Attribute>
        <Citation Type="general">
          <ID Source="PubMed">15937078</ID>
        </Citation>
      </ObservedData>
      <ObservedData ID="12728007">
        <Attribute Type="Description">Li et al. (2004) had previously reported the indel mutation as a 15-bp deletion, which they found in homozygosity in 6 Japanese and 2 Chinese families with BCD as well as in 1 Japanese and 2 Chinese sporadic BCD patients. In addition, they identified the indel mutation in compound heterozygous state with the IVS8-2A-G mutation (608614.0005) in a Chinese patient with sporadic BCD and with the H331P mutation in affected individuals from a Chinese family. Screening for these 3 mutations in 50 controls, including 12 of Chinese, 16 of Japanese, and 22 of European origin, detected only 1 heterozygous instance of the H331P mutation in 1 Chinese control sample.</Attribute>
        <Citation Type="general">
          <ID Source="PubMed">15042513</ID>
        </Citation>
      </ObservedData>
      <ObservedData ID="12728007">
        <Attribute Type="Description">In 4 Chinese sisters with congenital cataract, high myopia, thin corneas, and a diagnosis of retinitis pigmentosa, Wang et al. (2012) identified compound heterozygosity for the c.802-8_810del17insGC mutation and the IVS8-2A-G mutation in the CYP4V2 gene. The mutations segregated fully with disease in 22 examined members of this 4-generation family.</Attribute>
        <Citation Type="general">
          <ID Source="PubMed">22693542</ID>
        </Citation>
      </ObservedData>
      <ObservedData ID="12728007">
        <Attribute Type="Description">In the proband from a Chinese family diagnosed with autosomal recessive RP, Fu et al. (2013) identified compound heterozygosity for the CYP4V2 c.802-8_810del17insGC (c.802-8_810del17insGC, NM_207352.3) and IVS8-2A-G mutations. Both mutations were also present in an affected sib, but mutation status was unknown for their unaffected deceased parents. Clinical reevaluation was not possible in this family, but reexamination of affected individuals in another Chinese RP family with mutations in CYP4V2 resulted in a rediagnosis of their phenotype as BCD (see 608614.0009).</Attribute>
        <Citation Type="general">
          <ID Source="PubMed">23661369</ID>
        </Citation>
      </ObservedData>
    </ObservedIn>
    <MeasureSet Type="Variant" ID="39271">
      <Measure Type="Indel" ID="47877">
        <Name>
          <ElementValue Type="Preferred">NM_207352.3(CYP4V2):c.802-8_810del17insGC</ElementValue>
        </Name>
        <AttributeSet>
          <Attribute Change="c.802-8_810delinsGC" Accession="NM_207352" Version="3" Type="HGVS, coding">NM_207352.3:c.802-8_810delinsGC</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Change="c.802-8_810del17insGC" Accession="NM_207352" Version="3" Type="HGVS, coding, RefSeq">NM_207352.3:c.802-8_810del17insGC</Attribute>
          <XRef Type="Allelic variant" ID="608614.0006" DB="OMIM"/>
        </AttributeSet>
        <AttributeSet>
          <Attribute Change="g.14630_14646delinsGC" Accession="NG_007965" Version="1" Type="HGVS, genomic">NG_007965.1:g.14630_14646delinsGC</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Change="g.14630_14646del17insGC" Accession="NG_007965" Version="1" Type="HGVS, genomic, RefSeqGene">NG_007965.1:g.14630_14646del17insGC</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Change="g.186201149_186201165del17insGC" Accession="NC_000004" Version="12" Type="HGVS, genomic, top level" integerValue="38">NC_000004.12:g.186201149_186201165del17insGC</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Change="g.187122303_187122319del17insGC" Accession="NC_000004" Version="11" Type="HGVS, genomic, top level, previous" integerValue="37">NC_000004.11:g.187122303_187122319del17insGC</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="MolecularConsequence">intron variant</Attribute>
          <XRef ID="SO:0001627" DB="Sequence Ontology"/>
          <XRef ID="NM_207352.3:c.802-8_810del17insGC" DB="RefSeq"/>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="nucleotide change">IVS6-8 del/insGC</Attribute>
        </AttributeSet>
        <CytogeneticLocation>4q35.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.28" AssemblyStatus="current" Chr="4" Accession="NC_000004.12" start="186201149" stop="186201165" display_start="186201149" display_stop="186201165" alternateAllele="GC"/>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="4" Accession="NC_000004.11" start="187122303" stop="187122319" display_start="187122303" display_stop="187122319" alternateAllele="GC"/>
        <MeasureRelationship Type="variant in gene">
          <Name>
            <ElementValue Type="Preferred">cytochrome P450 family 4 subfamily V member 2</ElementValue>
          </Name>
          <Symbol>
            <ElementValue Type="Preferred">CYP4V2</ElementValue>
          </Symbol>
          <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.28" AssemblyStatus="current" Chr="4" Accession="NC_000004.12" start="186191520" stop="186213463" display_start="186191520" display_stop="186213463" Strand="+"/>
          <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="4" Accession="NC_000004.11" start="187112673" stop="187134616" display_start="187112673" display_stop="187134616" variantLength="21944" Strand="+"/>
          <XRef ID="285440" DB="Gene"/>
          <XRef Type="MIM" ID="608614" DB="OMIM"/>
          <XRef ID="HGNC:23198" DB="HGNC"/>
        </MeasureRelationship>
        <Citation Type="general">
          <ID Source="PubMed">15860296</ID>
        </Citation>
        <XRef Type="Allelic variant" ID="608614.0006" DB="OMIM"/>
        <XRef Type="rs" ID="207482233" DB="dbSNP"/>
      </Measure>
      <Name>
        <ElementValue Type="Preferred">NM_207352.3(CYP4V2):c.802-8_810del17insGC</ElementValue>
      </Name>
    </MeasureSet>
    <TraitSet Type="Disease" ID="559">
      <Trait ID="4671" Type="Disease">
        <Name>
          <ElementValue Type="Preferred">Bietti crystalline corneoretinal dystrophy</ElementValue>
          <XRef ID="Bietti+Crystalline+Corneoretinal+Dystrophy/825" DB="Genetic Alliance"/>
          <XRef ID="10050" DB="Office of Rare Diseases"/>
        </Name>
        <Name>
          <ElementValue Type="Alternate">Bietti Crystalline Dystrophy</ElementValue>
          <XRef ID="NBK91457" DB="GeneReviews"/>
        </Name>
        <Symbol>
          <ElementValue Type="Preferred">BCD</ElementValue>
          <XRef Type="MIM" ID="210370" DB="OMIM"/>
          <XRef ID="10050" DB="Office of Rare Diseases"/>
        </Symbol>
        <AttributeSet>
          <Attribute Type="public definition">Bietti crystalline dystrophy (BCD) is a chorioretinal degeneration characterized by the presence of yellow-white crystals and/or complex lipid deposits in the retina. Progressive atrophy and degeneration of the retinal pigment epithelium (RPE)/choroid lead to symptoms similar to those of other forms of retinal degeneration that fall under the category of retinitis pigmentosa and allied disorders, namely: reduced visual acuity, poor night vision, abnormal retinal electrophysiology, visual field loss, and often impaired color vision. Marked asymmetry between eyes is common. Onset is typically during the second to third decade of life, but ranges from the early teenage years to beyond the third decade. With time, loss of peripheral visual field, central acuity, or both result in legal blindness in most, if not all, affected individuals.</Attribute>
          <XRef ID="NBK91457" DB="GeneReviews"/>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance" integerValue="263">Autosomal recessive inheritance</Attribute>
          <XRef ID="GTR000506412" DB="Genetic Testing Registry (GTR)"/>
          <XRef ID="GTR000512554" DB="Genetic Testing Registry (GTR)"/>
        </AttributeSet>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">22497028</ID>
          <ID Source="BookShelf">NBK91457</ID>
        </Citation>
        <XRef ID="C1859486" DB="MedGen"/>
        <XRef Type="MIM" ID="210370" DB="OMIM"/>
      </Trait>
    </TraitSet>
  </ReferenceClinVarAssertion>
  <ClinVarAssertion ID="92690">
    <ClinVarSubmissionID localKey="IVS6-8 del/insGC_NBK91457" submitter="GeneReviews" submitterDate="2013-03-26" title="IVS6-8 del/insGC and Bietti Crystalline Dystrophy"/>
    <ClinVarAccession Acc="SCV000056215" Version="2" Type="SCV" OrgID="500062" DateUpdated="2016-08-29"/>
    <RecordStatus>current</RecordStatus>
    <ClinicalSignificance DateLastEvaluated="2012-04-12">
      <ReviewStatus>no assertion criteria provided</ReviewStatus>
      <Description>pathologic</Description>
    </ClinicalSignificance>
    <Assertion Type="variation to disease"/>
    <ExternalID DB="GeneReviews" ID="NBK91457"/>
    <ObservedIn>
      <Sample>
        <Origin>not provided</Origin>
        <Species>human</Species>
        <AffectedStatus>not provided</AffectedStatus>
      </Sample>
      <Method>
        <Purpose>Assert pathogenicity</Purpose>
        <MethodType>curation</MethodType>
      </Method>
      <ObservedData>
        <Attribute Type="Description">not provided</Attribute>
      </ObservedData>
    </ObservedIn>
    <MeasureSet Type="Variant">
      <Measure Type="Variation">
        <AttributeSet>
          <Attribute Type="nucleotide change">IVS6-8 del/insGC</Attribute>
        </AttributeSet>
      </Measure>
    </MeasureSet>
    <TraitSet Type="Disease">
      <Trait Type="Disease">
        <Name>
          <ElementValue Type="Preferred">Bietti Crystalline Dystrophy</ElementValue>
        </Name>
        <XRef DB="GeneReviews" ID="NBK91457"/>
        <XRef DB="OMIM" ID="210370" Type="MIM"/>
      </Trait>
    </TraitSet>
  </ClinVarAssertion>
  <ClinVarAssertion ID="310094" SubmissionName="targeted_exome_RP">
    <ClinVarSubmissionID localKey="NM_207352.3:c.802-8_810del17insGC|KYOTOUNIVOPHTHALMOL" submitter="Department of Ophthalmology and Visual Sciences Kyoto University" submitterDate="2014-07-29"/>
    <ClinVarAccession Acc="SCV000172674" Version="1" Type="SCV" OrgID="505202" DateUpdated="2015-06-27"/>
    <RecordStatus>current</RecordStatus>
    <ClinicalSignificance>
      <ReviewStatus>no assertion criteria provided</ReviewStatus>
      <Description>pathogenic</Description>
      <Comment>Converted during submission to Pathogenic.</Comment>
    </ClinicalSignificance>
    <Assertion Type="variation to disease"/>
    <ObservedIn>
      <Sample>
        <Origin>not provided</Origin>
        <Species>human</Species>
        <AffectedStatus>not provided</AffectedStatus>
        <NumberTested>1</NumberTested>
      </Sample>
      <Method>
        <MethodType>not provided</MethodType>
      </Method>
      <ObservedData>
        <Attribute Type="Description">not provided</Attribute>
      </ObservedData>
    </ObservedIn>
    <MeasureSet Type="Variant">
      <Measure Type="Variation">
        <AttributeSet>
          <Attribute Type="HGVS">NM_207352.3:c.802-8_810del17insGC</Attribute>
        </AttributeSet>
      </Measure>
    </MeasureSet>
    <TraitSet Type="Disease">
      <Trait Type="Disease">
        <Name>
          <ElementValue Type="Preferred">Bietti crystalline corneoretinal dystrophy</ElementValue>
        </Name>
        <XRef DB="OMIM" ID="210370" Type="MIM"/>
      </Trait>
    </TraitSet>
  </ClinVarAssertion>
  <ClinVarAssertion ID="457710">
    <ClinVarSubmissionID localKey="608614.0006_BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY" submitter="OMIM" submitterDate="2015-09-26" title="CYP4V2, IVS6AS, 17-BP DEL/2-BP INS_BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY"/>
    <ClinVarAccession Acc="SCV000246149" Version="1" Type="SCV" OrgID="3" DateUpdated="2015-10-11"/>
    <RecordStatus>current</RecordStatus>
    <ClinicalSignificance DateLastEvaluated="2013-06-14">
      <ReviewStatus>no assertion criteria provided</ReviewStatus>
      <Description>Pathogenic</Description>
    </ClinicalSignificance>
    <Assertion Type="variation to disease"/>
    <ExternalID DB="OMIM" ID="608614.0006" Type="Allelic variant"/>
    <ObservedIn>
      <Sample>
        <Origin>germline</Origin>
        <Species>human</Species>
        <AffectedStatus>not provided</AffectedStatus>
      </Sample>
      <Method>
        <MethodType>literature only</MethodType>
      </Method>
      <ObservedData>
        <Attribute Type="Description">In 7 Japanese patients with Bietti crystalline corneoretinal dystrophy (BCD; 210370), Lin et al. (2005) identified homozygosity for an insertion/deletion mutation (c.802-8_810del17insGC) at intron 6 of the CYP4V2 gene that resulted in the skipping of exon 7. All 7 patients also shared homozygosity for 6 closely linked intragenic polymorphic markers, consistent with a founder effect; however, the authors noted that the founder was probably a very distant ancestor because the region of the conserved linked markers was small (6.7-17.1 kb). In a Chinese BCD patient, Lin et al. (2005) identified compound heterozygosity for this mutation and a c.992A-C transversion in the CYP4V2 gene, resulting in a his-331-to-pro (H331P; 608614.0007) substitution.</Attribute>
        <Citation>
          <ID Source="PubMed">15937078</ID>
        </Citation>
        <XRef DB="OMIM" ID="210370" Type="MIM"/>
      </ObservedData>
      <ObservedData>
        <Attribute Type="Description">Li et al. (2004) had previously reported the indel mutation as a 15-bp deletion, which they found in homozygosity in 6 Japanese and 2 Chinese families with BCD as well as in 1 Japanese and 2 Chinese sporadic BCD patients. In addition, they identified the indel mutation in compound heterozygous state with the IVS8-2A-G mutation (608614.0005) in a Chinese patient with sporadic BCD and with the H331P mutation in affected individuals from a Chinese family. Screening for these 3 mutations in 50 controls, including 12 of Chinese, 16 of Japanese, and 22 of European origin, detected only 1 heterozygous instance of the H331P mutation in 1 Chinese control sample.</Attribute>
        <Citation>
          <ID Source="PubMed">15042513</ID>
        </Citation>
      </ObservedData>
      <ObservedData>
        <Attribute Type="Description">In 4 Chinese sisters with congenital cataract, high myopia, thin corneas, and a diagnosis of retinitis pigmentosa, Wang et al. (2012) identified compound heterozygosity for the c.802-8_810del17insGC mutation and the IVS8-2A-G mutation in the CYP4V2 gene. The mutations segregated fully with disease in 22 examined members of this 4-generation family.</Attribute>
        <Citation>
          <ID Source="PubMed">22693542</ID>
        </Citation>
      </ObservedData>
      <ObservedData>
        <Attribute Type="Description">In the proband from a Chinese family diagnosed with autosomal recessive RP, Fu et al. (2013) identified compound heterozygosity for the CYP4V2 c.802-8_810del17insGC (c.802-8_810del17insGC, NM_207352.3) and IVS8-2A-G mutations. Both mutations were also present in an affected sib, but mutation status was unknown for their unaffected deceased parents. Clinical reevaluation was not possible in this family, but reexamination of affected individuals in another Chinese RP family with mutations in CYP4V2 resulted in a rediagnosis of their phenotype as BCD (see 608614.0009).</Attribute>
        <Citation>
          <ID Source="PubMed">23661369</ID>
        </Citation>
      </ObservedData>
    </ObservedIn>
    <MeasureSet Type="Variant">
      <Measure Type="Variation">
        <Name>
          <ElementValue Type="Preferred">CYP4V2, IVS6AS, 17-BP DEL/2-BP INS</ElementValue>
        </Name>
        <AttributeSet>
          <Attribute Type="NonHGVS">IVS6AS, 17-BP DEL/2-BP INS</Attribute>
        </AttributeSet>
        <MeasureRelationship Type="variant in gene">
          <Symbol>
            <ElementValue Type="Preferred">CYP4V2</ElementValue>
          </Symbol>
        </MeasureRelationship>
        <XRef DB="OMIM" ID="608614.0006" Type="Allelic variant"/>
      </Measure>
    </MeasureSet>
    <TraitSet Type="Disease">
      <Trait Type="Disease">
        <Name>
          <ElementValue Type="Preferred">BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY</ElementValue>
        </Name>
      </Trait>
    </TraitSet>
  </ClinVarAssertion>
</ClinVarSet>
</ReleaseSet>
